JAMES RUDGE, Technical Director, Neoteryx

James Rudge, PhD, is Technical Director at Neoteryx, the Microsampling Business Unit of Trajan Scientific and Medical. He is a co-inventor of the company’s Mitra® device and its patented VAMS® technology. Dr. Rudge has co-authored 12 papers on VAMS microsampling with global collaborators, and he authored a new book chapter on VAMS in 2021. Among recent events and speaking engagements, Dr. Rudge was a plenary speaker at the 2021 CPSA (Clinical & Pharmaceutical Solutions through Analysis) EU virtual conference and chaired a session at the Outsourcing Clinical Trials conference UK & Ireland focusing on remote clinical trials. He is involved in several global research collaborations, including a large European research consortium addressing unmet needs in inflammatory disease.